Tubal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-08-13
Clinical Trial Update: A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable [Phase 2]
Phase 2 study evaluating neoadjuvant bevacizumab (Avastin) in patients with initially unresectable FIGO stage IIIC/IV ovarian, tubal, or per…